Meeting the International Health Regulations (2005) surveillance core capacity requirements at the subnational level in Europe: The added value of syndromic surveillance

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Ziemann, Alexandra ^a   Rosenkötter, Nicole ^a   Riesgo, Luis Garcia Castrillo ^b   Fischer, Matthias ^c   Krämer, Alexander ^d   Lippert, Freddy K ^e,f   Vergeiner, Gernot ^g   Brand, Helmut ^a   Krafft, Thomas ^a,h,i  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c KLINIK AM EICHERT   (Germany)

^d BIELEFELD UNIVERSITY   (Germany)

^e Head Office The Capital Region of Denmark   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g Dispatch Centre Tyrol (Leitstelle Tirol Gesellschaft MbH)   (Austria)

^h BHARATI VIDYAPEETH UNIVERSITY   (India)

ⁱ INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Europe; Public health surveillance; World health organization

Indexed keywords

COMMUNICABLE DISEASES; DISASTER PLANNING; EMERGENCY; EUROPE; HEALTH SURVEY; HUMAN; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; PROCEDURES; TIME; WORLD HEALTH ORGANIZATION;

COMMUNICABLE DISEASES; DISASTER PLANNING; EMERGENCIES; EUROPE; HUMANS; INTERNATIONALITY; PUBLIC HEALTH SURVEILLANCE; TIME FACTORS; WORLD HEALTH ORGANIZATION;

EID: 84924066661     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1421-2     Document Type: Review

References (68)

1. World Health Organization. International Health Regulations (2005). Geneva: World Health Organization; 2008.
2. Paquet C, Coulombier D, Kaiser R, Ciotti M. Epidemic intelligence: A new framework for strengthening disease surveillance in Europe. Euro Surveill. 2006;11(12):212-214.
3. World Health Organization. European Strategy Meeting for implementation of the International Health Regulations (2005) - Scope and purpose. Copenhagen: World Health Organization; 2013.
4. Allebeck P. Which health data for Europe? Eur J Public Health. 2012;22(5):611.
5. European Parliament and Council of the European Union. Decision on serious cross-border threats to health and repealing Decision No 2119/98/EC (1082/2013/EU). Off J Eur Union. 2013;L 293:1-15.
6. European Commission. Commission Implementing Decision amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (2012/506/EU). Off J Eur Union. 2012;L262:1-57.
7. Mostashari F, Hartman J. Syndromic surveillance: A local perspective. J Urban Health. 2003;80(2 Suppl 1):i1-i7.
8. McManus J, Huebner K, Scheulen J. The science of surge: Detection and situational awareness. Acad Emerg Med. 2006;13(11):1179-1182.
9. Lyytikainen O, Kuusi M, Snellman M, Virtanen M, Eskola J, Ronkko E, et al. Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010. Euro Surveill. 2011;16(27). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19908.
10. Wilson K, McDougall C, Forster A. The responsibility of healthcare institutions to protect global health security. Healthc Q. 2009;12(1):56-60.
11. Altmann M, Spode A, Altmann D, Wadl M, Benzler J, Eckmanns T, et al. Timeliness of surveillance during outbreak of Shiga Toxin-producing Escherichia coli infection, Germany, 2011. Emerg Infect Dis. 2011;17(10):1906-1909.
12. Triple S. Assessment of syndromic surveillance in Europe. Lancet. 2011;378 (9806):1833-1834.
13. Conti S, Kanieff M, Rago G. Inventory of syndromic surveillance systems in Europe. Triple S-AGE project; 2012. [http://www.syndromicsurveillance.eu/triple-s-inventory-report.pdf].
14. Ziemann A, Krafft T. Guidelines for assessment of data sources. Triple S-AGE project; 2013. [http://www.syndromicsurveillance.eu/triple-s-guidelines-datasources.pdf].
15. Paterson BJ, Durrheim DN. The remarkable adaptability of syndromic surveillance to meet public health needs. J Epidemiol Global Health. 2013;3(1):41-47.
16. Kaydos-Daniels SC, Rojas Smith L, Farris TR. Biosurveillance in outbreak investigations. Biosecur Bioterror. 2013;11(1):20-28.
17. Koopmans M. Surveillance strategy for early detection of unusual infectious disease events. Curr Opin Virol. 2013;3(2):185-191.
18. Morse SS. Public health surveillance and infectious disease detection. Biosecur Bioterror. 2012;10(1):6-16.
19. Revision of the International Health Regulations. Progress report, February 2001. Wkly Epidemiol Rec. 2001;8:61-63.
20. Ziemann A, Krafft T, Sala Soler M, Sypniewska P. Country visits. Triple S-AGE project; 2013 [http://syndromicsurveillance.eu/images/stories/Final-material/triple-S-country-visits.pdf].
21. Rosenkötter N, Ziemann A, Garcia-Castrillo Riesgo L, Gillet JB, Vergeiner G, Krafft T, et al. Validity and timeliness of syndromic influenza surveillance during the autumn/winter wave of A(H1N1) influenza 2009: results of emergency medical dispatch, ambulance and emergency department data from three European regions. BMC Public Health. 2013;13(1):905.
22. Bollaerts K, Antoine J, Robesyn E, Van Proeyen L, Vomberg J, Feys E, et al. Timeliness of syndromic influenza surveillance through work and school absenteeism. Arch Public Health. 2010;68:115-120.
23. Harder KM, Andersen PH, Baehr I, Nielsen LP, Ethelberg S, Glismann S, et al. Electronic real-time surveillance for influenza-like illness: experience from the 2009 influenza A(H1N1) pandemic in Denmark. Euro Surveill. 2011;16(3). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19767.
24. Gerbier-Colomban S, Potinet-Pagliaroli V, Metzger MH. Can epidemic detection systems at the hospital level complement regional surveillance networks: case study with the influenza epidemic? BMC Infect Dis. 2014;14:381.
25. Brabazon ED, Carton MW, Murray C, Hederman L, Bedford D. General practice out-of-hours service in Ireland provides a new source of syndromic surveillance data on influenza. Euro Surveill. 2010;15(31). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19632.
26. Ansaldi F, Orsi A, Altomonte F, Bertone G, Parodi V, Carloni R, et al. Emergency department syndromic surveillance syndromic surveillancetem for early detection of 5 syndromes: A pilot project in a reference teaching hospital in Genoa. Italy J Prev Med Hyg. 2008;49(4):131-135.
27. Amicizia D, Cremonesi I, Carloni R, Schiaffino S. The response of the Liguria Region (Italy) to the pandemic influenza virus A/H1N1sv. J Prev Med Hyg. 2011;52(3):120-123.
28. Schrell S, Ziemann A, Garcia-Castrillo Riesgo L, Rosenkotter N, Llorca J, Popa D, et al. Local implementation of a syndromic influenza surveillance syndromic surveillance tem using emergency department data in Santander, Spain. J Public Health (Oxf). 2013;35(3):397-403.
29. Hulth A, Rydevik G, Linde A. Web queries as a source for syndromic surveillance. PLoS One. 2009;4(2):e4378.
30. Hulth A, Rydevik G. Web query-based surveillance in Sweden during the influenza A(H1N1)2009 pandemic, April 2009 to February 2010. Euro Surveill. 2011;16(18). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19856.
31. Hulth A, Rydevik G. GET WELL: An automated surveillance syndromic surveillance tem for gaining new epidemiological knowledge. BMC Public Health. 2011;11:252.
32. Smith S, Smith GE, Olowokure B, Ibbotson S, Foord D, Maguire H, et al. Early spread of the 2009 influenza A(H1N1) pandemic in the United Kingdom-use of local syndromic data, May-August 2009. Euro Surveill. 2011;16(3). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19771.
33. Cooper DL, Verlander NQ, Elliot AJ, Joseph CA, Smith GE. Can syndromic thresholds provide early warning of national influenza outbreaks? J Public Health (Oxf). 2009;31(1):17-25.
34. Harcourt SE, Smith GE, Elliot AJ, Pebody R, Charlett A, Ibbotson S, et al. Use of a large general practice syndromic surveillance syndromic surveillancetem to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK. Epidemiol Infect. 2012;140(1):100-105.
35. Kara EO, Elliot AJ, Bagnall H, Foord DG, Pnaiser R, Osman H, et al. Absenteeism in schools during the 2009 influenza A(H1N1) pandemic: A useful tool for early detection of influenza activity in the community? Epidemiol Infect. 2012;140(7):1328-1336.
36. Todd S, Diggle PJ, White PJ, Fearne A, Read JM. The spatiotemporal association of non-prescription retail sales with cases during the 2009 influenza pandemic in Great Britain. BMJ Open. 2014;4(4):e004869.
37. Kavanagh K, Robertson C, Murdoch H, Crooks G, McMenamin J. Syndromic surveillance of influenza-like illness in Scotland during the influenza A H1N1v pandemic and beyond. J R Stat Soc (Series A). 2012;175:939-58.
38. Valdivia A, Lopez-Alcalde J, Vicente M, Pichiule M, Ruiz M, Ordobas M. Monitoring influenza activity in Europe with Google Flu Trends: comparison with the findings of sentinel physician networks - results for 2009-10. Euro Surveill. 2010;15(29). Available online: http://www.eurosurveillance.org/View-Article.aspx?ArticleId=19621.
39. European Centre for Disease Prevention and Control. Second Interim Threat Assessment. Ash cloud following volcanic eruption in Iceland, 20 April 11:00 CET. Stockholm: ECDC; 2010.
40. World Health Organization Regional Office for Europe. WHO/Europe expert group concludes Icelandic volcanic ash currently poses no threat to public health. [http://www.euro.who.int/en/health-topics/environment-and-health/air-quality/news/news/2010/05/whoeurope-expert-group-concludesicelandic-volcanic-ash-currently-poses-no-threat-to-public-health].
41. Rosenkötter N, Ziemann A, Garcia-Castrillo Riesgo L, Vergeiner G, Fischer M, Krafft T, et al. SIDARTHa Volcanic Ash Cloud Rapid Public Health Impact Assessment. Regional public health impact of volcanic ash cloud covering Europe after eruption of Eyjafjallajoekull, Iceland starting April 14th, 2010. Results as of May 15th, 2010. Bad Honnef: SIDARTHa project; 2010.
42. Elliot AJ, Singh N, Loveridge P, Harcourt S, Smith S, Pnaiser R, et al. Syndromic surveillance to assess the potential public health impact of the Icelandic volcanic ash plume across the United Kingdom, April 2010. Euro Surveill. 2010;15(23). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19583.
43. Robert Koch-Institut. Final presentation and evaluation of epidemiological findings in the EHEC O104:H4 Outbreak, Germany 2011. Berlin: Robert Koch-Institute; 2011.
44. Wadl M, Rieck T, Nachtnebel M, Greutelaers B, Van der Heiden M, Altmann D, et al. Enhanced surveillance during a large outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/verotoxinproducing Escherichia coli in Germany, May to June 2011. Euro Surveil. 2011;16(24):19893.
45. Dailey L, Watkins RE, Plant AJ. Timeliness of data sources used for influenza surveillance. J Am Med Inform Assoc. 2007;14(5):626-31.
46. Rosenkötter N, Ziemann A, Krafft T, Riesgo LG, Vergeiner G, Brand H. Non-infectious events under the International Health Regulations (2005) in Europe - A case for syndromic surveillance. J Public Health Policy. 2014;35(3):311-326.
47. Coory MD, Kelly H, Tippett V. Assessment of ambulance dispatch data for surveillance of influenza-like illness in Melbourne, Australia. Public Health. 2009;123(2):163-168.
48. Xing J, Burkom H, Tokars J. Method selection and adaptation for distributed monitoring of infectious diseases for syndromic surveillance. J Biomed Inform. 2011;44(6):1093-1101.
49. van den Wijngaard C, van Asten L, van Pelt W, Nagelkerke NJ, Verheij R, de Neeling AJ, et al. Validation of syndromic surveillance for respiratory pathogen activity. Emerg Infect Dis. 2008;14(6):917-925.
50. Mook P, Joseph C, Gates P, Phin N. Pilot scheme for monitoring sickness absence in schools during the 2006/07 winter in England: can these data be used as a proxy for influenza activity? Euro Surveill. 2007;12(12):E11-E12.
51. Schmidt WP, Pebody R, Mangtani P. School absence data for influenza surveillance: A pilot study in the United Kingdom. Euro Surveill. 2010;15(3). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19467.
52. Aguilera JF, Paget WJ, Mosnier A, Heijnen ML, Uphoff H, van der Velden J, et al. Heterogeneous case definitions used for the surveillance of influenza in Europe. Eur J Epidemiol. 2003;18(8):751-754.
53. Paget J, Marquet R, Meijer A, van der Velden K. Influenza activity in Europe during eight seasons (1999-2007): An evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe. BMC Infect Dis. 2007;7:141.
54. Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, Pitigoi D, et al. "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill. 2009;14(44). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19388.
55. EuroMOMO. [http://www.euromomo.eu].
56. Medina S, Fouillet A, Ziemann A, Krafft T, Cooper D, Dupuy C, et al. Proposal for a European strategy for syndromic surveillance. Toward comparability of reporting from syndromic surveillance systems in Europe. Triple S-AGE project. 2013 [http://syndromicsurveillance.eu/Triple-S-proposal.pdf].
57. Cooper DL, Smith G, Baker M, Chinemana F, Verlander N, Gerard E, et al. National symptom surveillance using calls to a telephone health advice service-United Kingdom, December 2001-February 2003. MMWR Morb Mortal Wkly Rep. 2004;53(Suppl):179-183.
58. Flamand C, Larrieu S, Couvy F, Jouves B, Josseran L, Filleul L. Validation of a syndromic surveillance syndromic surveillancetem using a general practitioner house calls network, Bordeaux, France. Euro Surveill. 2008;13(25). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18905.
59. Josseran L, Nicolau J, Caillere N, Astagneau P, Brucker G. Syndromic surveillance based on emergency department activity and crude mortality: Two examples. Euro Surveill. 2006;11(12):225-229.
60. Guasticchi G, Giorgi Rossi P, Lori G, Genio S, Biagetti F, Gabriele S, et al. Syndromic surveillance: Sensitivity and positive predictive value of the case definitions. Epidemiol Infect. 2009;137(5):662-671.
61. Davies GR, Finch RG. Sales of over-the-counter remedies as an early warning syndromic surveillancetem for winter bed crises. Clin Microbiol Infect. 2003;9(8):858-863.
62. Buehler JW, Hopkins RS, Overhage JM, Sosin DM, Tong V. Framework for evaluating public health surveillance systems for early detection of outbreaks: recommendations from the CDC Working Group. MMWR Recomm Rep. 2004;53(RR-5):1-11.
63. Ziemann A, Krafft T. Scientific visit guidelines for knowledge exchange on syndromic surveillance in Europe. Triple S-AGE project. 2011 [http://syndromicsurveillance.eu/triple-s-scientific-visit-guidelines.pdf].
64. Bounoure F, Beaudeau P, Mouly D, Skiba M, Lahiani-Skiba M. Syndromic surveillance of acute gastroenteritis based on drug consumption. Epidemiol Infect. 2011;139(9):1388-1395.
65. Buehler JW, Whitney EA, Smith D, Prietula MJ, Stanton SH, Isakov AP. Situational uses of syndromic surveillance. Biosecur Bioterror. 2009;7(2):165-177.
66. EuroREACH. Good practice on data linkages and performance measurement in relation to access to national health care data systems. [http://www.euroreach.net/sites/default/files/EuroREACH-WP3%20Final%20Report.pdf].
67. SIDARTHa. [http://www.sidartha.eu].
68. Ziemann A, Rosenkötter N, Garcia-Castrillo Riesgo L, Schrell S, Kauhl B, Vergeiner G, et al. A concept for routine emergency-care data-based syndromic surveillance in Europe. Epidemiol Infect. 2014;142(11):2433-2446.